NCT04793529 is a NA clinical trial of Cholecalciferol in Verruca Vulgaris, sponsored by Benha University.

Who is sponsoring NCT04793529?

NCT04793529 is sponsored by Benha University.

What drugs are being tested in NCT04793529?

Interventions in NCT04793529: Cholecalciferol.

What condition does NCT04793529 study?

NCT04793529 studies Verruca Vulgaris, Involucrin.

Is NCT04793529 still recruiting?

NCT04793529 is currently completed. Last updated 27 July 2023.

Last reviewed 2023-07-27 · How we verify

NCT04793529

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Is Involucrin Has a Role in Verruca Vulgaris? A Clinical and Immunohistochemical Study

Completed NA Last updated 27 July 2023

What this trial tests

NA trial testing Cholecalciferol in Verruca Vulgaris in 60 participants. Completed in 1 October 2019.

Timeline

1 January 2019

Primary endpoint
1 October 2019

1 October 2019

Quick facts

Lead sponsor	Benha University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	1 January 2019
Primary completion	1 October 2019
Estimated completion	1 October 2019
Sites	1 location across Egypt

Drugs / interventions tested

Cholecalciferol (cholecalciferol) — full drug profile →

Conditions studied

Verruca Vulgaris — all drugs for Verruca Vulgaris →
Involucrin — all drugs for Involucrin →

Sponsor

Benha University

Who can join

Adults 18 to 45, any sex, with Verruca Vulgaris or Involucrin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Vitamin D3 plays important role in keratinocyte differentiation and had been used recently in verruca vulgaris. Aim of the work: To assess the expression of involucrin in verrucae vulgaris before and after injection of vitamin D3. Subjects and Methods: This study included 60 patients with verrucae vulgaris subjected to intralesional injection of vitamin D3 at three weeks interval for a maximum of five sessions. Immunohistochemical assessment of involucrin was done before and after injection and compared to skin biopsies from 30 healthy individuals

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Does involucrin have a Role in Verruca Vulgaris? A Clinical and Immunohistochemical Study.
Akl EM, Sorour NE, Abdou AG, Elesawy FM. · · 2021 · PMID 35068499 · DOI 10.4103/ijd.ijd_808_20

Verify or expand the search:

Other trials of Cholecalciferol

Trials testing the same drug.

NCT06847373 — Efficacy and Safety of Vitamin D Supplementation in Pediatric Patients with Obesity · NA · recruiting
NCT06447441 — Clinical Outcomes Of Mega-dosage Supplementations Of Cholecalciferol In Critically Ill Patients With Sepsis · NA · not yet recruiting
NCT06301178 — Effect of Vitamin D Injection on Hypertrophic Scars and Keloids · Phase 1, PHASE2 · completed
NCT06053281 — The Role of Vitamin D in Neuroinflammatory on Drug Resistant Epilepsy · EARLY_PHASE1 · unknown
NCT05860270 — Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis · Phase 4 · recruiting

Other Benha University trials

Trials by the same sponsor.

NCT07526675 — Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer · NA · not yet recruiting
NCT07480031 — Determination of the Optimal Inspiratory Pressure to Decrease Incidence of Gastric Insufflation With Adequate Ventilatio · NA · not yet recruiting
NCT07465185 — Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery · Phase 2 · recruiting
NCT07467356 — Anterior Iliopsoas Space Block Versus PENG Block on Ease of Positioning for Spinal Anathesia in Patients Undergoing Hip · Phase 3 · recruiting
NCT07300787 — miRNA in Pediatric Gastritis · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04793529 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Benha University
Last refreshed: 27 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04793529.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing